The predicted pattern of emergence of vaccine-resistant hepatitis B: A cause for concern?

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 973-978

  Wilson, Jamie N ^a   Nokes, D James ^b   Carman, William F ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Escape mutants; HBV; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; GAMBIA; HEPATITIS B; IMMUNITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; VACCINATION; VIRUS TRANSMISSION;

ADULT; CHILD; CROSS REACTIONS; GAMBIA; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INCIDENCE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 0033605352     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00313-2     Document Type: Article

References (24)

1. Ngui S.L., O'Connell S., Eglin R.P., et al. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis. 176:1997;5-1360.
2. Nainan O.V., Stevens C.E., Taylor P.E., Margolis H.S. Hepatitis B virus (HBV) antibody resistant mutants among mothers and infants with chronic HBV infection. In: Purcell R.H., Gerin J.L., Verme G., editors. International Symposium on Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica, 1997. p. 132.
3. Carman W.F., Zanetti A.R., Karayiannis P., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 336:1990;9-325.
4. Oon C.J., Lim G.K., Ye Z., et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine. 13:1995;699-702.
5. Hsu H.Y., Chang M.H., Ni Y.H., et al. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology. 26:1997;91-786.
6. Carman W.F., Korula J., Wallace L., et al. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet. 345:1995;7-140.
7. Surya I.G.P., Kishimoto S., Sudaryat S., et al. Prevention of mother-to-infant transmission of hepatitis B virus with use of a preS2-containing vaccine in Bali, Indonesia. Vaccine Research. 5:1996;13-6203.
8. Okamoto H., Yano K., Nozaki Y., et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res. 32:1992;8-264.
9. McMahon G., Ehrlich P.H., Moustafa Z.A., et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology. 15:1992;66-757.
10. Carman W.F., Trautwein C., van Deursen F.J., et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology. 24:1996;93-489.
11. Fortuin M., Karthigesu V., Allison L., et al. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis. 169:1994;6-1374.
12. Yamamoto K., Horikita M., Tsuda F., et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol. 68:1994;6-2671.
13. Edmunds W.J., Medley G.F., Nokes D.J. The transmission dynamics and control of hepatitis B virus in The Gambia. Stat Med. 15:1996;33-2215.
14. McLean A.R. Vaccination, evolution and changes in the efficacy of vaccines - a theoretical framework. Proceedings of the Royal Society Of London Series B-Biological Sciences. 261:1995;93-389.
15. McLean A.R., Nowak M.A. Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV. AIDS. 6:1992;9-71.
16. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford Science Publications, 1991.
17. Edmunds W.J., Medley G.F., Nokes D.J., et al. The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond B Biol Sci. 253:1993;197-201.
18. Edmunds WJ. The epidemiology and control of hepatitis B virus in highly endemic areas. Ph.D. Thesis. Department of Biology, Imperial College, London, 1994.
19. Ogata N., Zanetti A.R., Yu M., et al. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. The Journal of Infectious Diseases. 175:1997;23-511.
20. Whittle H.C., Maine N., Pilkington J., et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet. 345:1995;92-1089.
21. van Deursen F.J., Hino K., Wyatt D., et al. Use of PCR in resolving diagnostic difficulties potentially caused by genetic variation of hepatitis B virus. J Clin Path. 51:1998;53-149.
22. Wallace L.A., Carman W.F. Surface gene variation of HBV: scientific and medical relevance. Viral Hepatitis Reviews. 3:1997;5-16.
23. Edmunds W.J., Medley G.F., Nokes D.J., et al. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect. 117:1996;25-313.
24. Akahane Y. Clinical trial of a preS2-containing recombinant hepatitis B vaccine. International Symposium on Viral Hepatitis and Liver Disease, 1994.